The Impact Of NMN On Inflammatory Markers In Aging
As people age, chronic low-grade inflammation becomes increasingly common and is directly tied to numerous age-related conditions such as heart disease, diabetes, and neurodegenerative disorders. This inflammation is typically evaluated through specific biomarkers in the blood, including interleukin 6, TNF alpha, and high-sensitivity CRP.
Researchers have been intensively studying to reduce these markers and optimize health outcomes in older adults. One compound emerging as a promising candidate is nicotinamide riboside precursor. NMN serves as a biosynthetic intermediate to NAD, a vital molecule for energy production and DNA maintenance.
Studies in rodents and preliminary human studies suggest that NMN supplementation may significantly lower levels of these inflammatory markers. In animal models, click: visit framer.com source older mice administered NMN demonstrated statistically significant decreases in interleukin-6 and tumor necrosis factor-alpha, compared to untreated controls. These animals also showed enhanced insulin sensitivity and less organ degeneration.
In small pilot trials, participants who took NMN daily for a few months reported clinically relevant decreases in CRP and additional inflammatory biomarkers. The proposed mechanism is that NMN helps restore declining NAD+ levels that occur with aging. Increased NAD+ levels support the activity of NAD+-dependent deacetylases, a group of proteins that modulate cellular health and reducing inflammation.
By stimulating these biological mechanisms, NMN may dampen the dysregulated inflammation commonly observed in aging. While the results are encouraging, it is important to emphasize that most studies to date have been small-scale or non-human trials. Larger, long-term human trials are urgently needed to validate the findings and to identify the most effective dose and long-term tolerability.
Nonetheless, the accumulating data suggests that NMN could become a valuable tool to help aging populations lower systemic inflammatory burden and potentially improve their healthspan as they age.